Mymetics Corporation (MYMX)

Market Cap	46.00 -100.0%
Revenue (ttm)	564.14K -44.7%
Net Income	-12.24M
EPS	-80.61
Shares Out	151.88K
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	101
Open	0.0003
Previous Close	0.0003
Day's Range	0.0003 - 0.0003
52-Week Range	0.0003 - 0.0003
Beta	2.14
Analysts	n/a
Price Target	n/a
Earnings Date	May 28, 2026

About Mymetics

Mymetics Corporation engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company’s product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, and malaria. Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; and national institutes of health. The company was formerly known as ICHOR Corporation and changed its name to Mymetics Corporation in July 2001. Mymetics Corpora...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1990
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: MYMX